Literature DB >> 22374429

Histological ulceration as a prognostic factor in cutaneous melanoma: a study of 423 cases in Spain.

José Antonio Avilés-Izquierdo1, Pablo Lázaro-Ochaita.   

Abstract

INTRODUCTION: Histological ulceration in cutaneous melanoma carries a high risk of metastasis and has a poor prognosis. However, some epidemiological and survival studies of patients with cutaneous melanoma do not consider histological ulceration as one of the main prognostic factors.
MATERIALS AND METHODS: Epidemiological, clinical, histological and survival characteristics of all patients diagnosed with cutaneous melanoma over a 10-year period (1994- 2003) were retrospectively analysed.
RESULTS: Ulcerated melanoma was observed in 77 of 423 patients (18.2%). Ulceration was significantly associated with male sex, deeper tumour thickness, positive sentinel lymph node biopsy and metastasis (p<0.001). Histological ulceration indicates a high relative risk (RR) of death from melanoma (RR 9.41; 95% CI 4.52-19.59) and a significant risk of metastasis (RR 5.72; 95% CI 3.56-9.19) (p<0.001).
CONCLUSIONS: Histological ulceration is associated with lower overall survival and disease-free survival in patients with cutaneous melanoma. Presence of ulceration must be included in the clinical history of patients with melanoma to ensure a careful diagnostic work-up and follow-up.

Entities:  

Mesh:

Year:  2012        PMID: 22374429     DOI: 10.1007/s12094-012-0790-6

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  24 in total

Review 1.  Melanoma incidence trends.

Authors:  Caroline Bevona; Arthur J Sober
Journal:  Dermatol Clin       Date:  2002-10       Impact factor: 3.478

Review 2.  Staging and prognosis of cutaneous melanoma.

Authors:  Paxton V Dickson; Jeffrey E Gershenwald
Journal:  Surg Oncol Clin N Am       Date:  2011-01       Impact factor: 3.495

3.  Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.

Authors:  C M Balch; S J Soong; J E Gershenwald; J F Thompson; D S Reintgen; N Cascinelli; M Urist; K M McMasters; M I Ross; J M Kirkwood; M B Atkins; J A Thompson; D G Coit; D Byrd; R Desmond; Y Zhang; P Y Liu; G H Lyman; A Morabito
Journal:  J Clin Oncol       Date:  2001-08-15       Impact factor: 44.544

4.  Cancer surveillance series: changing patterns of cutaneous malignant melanoma mortality rates among whites in the United States.

Authors:  A Jemal; S S Devesa; T R Fears; P Hartge
Journal:  J Natl Cancer Inst       Date:  2000-05-17       Impact factor: 13.506

5.  Model predicting survival in stage I melanoma based on tumor progression.

Authors:  W H Clark; D E Elder; D Guerry; L E Braitman; B J Trock; D Schultz; M Synnestvedt; A C Halpern
Journal:  J Natl Cancer Inst       Date:  1989-12-20       Impact factor: 13.506

6.  Prognosis of thick cutaneous melanoma.

Authors:  S H Kim; C Garcia; J Rodriguez; D G Coit
Journal:  J Am Coll Surg       Date:  1999-03       Impact factor: 6.113

Review 7.  The nature of melanoma. A critical review.

Authors:  V J McGovern
Journal:  J Cutan Pathol       Date:  1982-04       Impact factor: 1.587

8.  Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions.

Authors:  R Corona; A Mele; M Amini; G De Rosa; G Coppola; P Piccardi; M Fucci; P Pasquini; T Faraggiana
Journal:  J Clin Oncol       Date:  1996-04       Impact factor: 44.544

9.  [Primary malignant melanoma of the skin. Retrospective study of 375 cases. Clinical aspects and histology].

Authors:  T Castel; M Baradad; J Castro; J M Mascaró; J C García-Valdecasas; L Grande; J Fuster; J Visa; J Estapé
Journal:  Med Clin (Barc)       Date:  1990-02-24       Impact factor: 1.725

10.  Prognostic parameters in localised melanoma: gender versus anatomical location.

Authors:  C P Karakousis; D L Driscoll
Journal:  Eur J Cancer       Date:  1995       Impact factor: 9.162

View more
  5 in total

1.  Why do patients with thick melanoma have different outcomes? A retrospective epidemiological and survival analysis.

Authors:  E Rodríguez-Lomba; I Marquez-Rodas; E Mercader-Cidoncha; R Suárez-Fernández; J A Avilés-Izquierdo
Journal:  Clin Transl Oncol       Date:  2017-03-01       Impact factor: 3.405

2.  Immune biomarkers are more accurate in prediction of survival in ulcerated than in non-ulcerated primary melanomas.

Authors:  Ellen H de Moll; Yichun Fu; Yingzhi Qian; Sara H Perkins; Shira Wieder; Sacha Gnjatic; Romain Remark; Sebastian G Bernardo; Marina Moskalenko; Jonathan Yao; Tammie Ferringer; Rui Chang; Jerry Chipuk; Basil A Horst; Miriam B Birge; Robert G Phelps; Yvonne M Saenger
Journal:  Cancer Immunol Immunother       Date:  2015-06-16       Impact factor: 6.968

Review 3.  Emerging Biomarkers in Cutaneous Melanoma.

Authors:  Anna Eisenstein; Estela Chen Gonzalez; Rekha Raghunathan; Xixi Xu; Muzhou Wu; Emily O McLean; Jean McGee; Byungwoo Ryu; Rhoda M Alani
Journal:  Mol Diagn Ther       Date:  2018-04       Impact factor: 4.074

Review 4.  Ulcerated Cutaneous Melanoma: A Review of the Clinical, Histologic, and Molecular Features Associated with a Clinically Aggressive Histologic Phenotype.

Authors:  Zoe Barricklow; Mallory J DiVincenzo; Colin D Angell; William E Carson
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-08-30

5.  Aberrant RNA Splicing Events Driven by Mutations of RNA-Binding Proteins as Indicators for Skin Cutaneous Melanoma Prognosis.

Authors:  Chao Mei; Pei-Yuan Song; Wei Zhang; Hong-Hao Zhou; Xi Li; Zhao-Qian Liu
Journal:  Front Oncol       Date:  2020-10-15       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.